HemaSphere (Jun 2022)
S127: QUIZARTINIB WITH DECITABINE AND VENETOCLAX (TRIPLET) IS ACTIVE IN PATIENTS WITH FLT3-ITD MUTATED ACUTE MYELOID LEUKEMIA - A PHASE I/II STUDY
- M. Yilmaz,
- M. Muftuoglu,
- H. Kantarjian,
- C. DiNardo,
- T. Kadia,
- G. Borthakur,
- N. Pemmaraju,
- N. Short,
- Y. Alvarado,
- A. Maiti,
- L. Masarova,
- G. Montalban Bravo,
- S. Loghavi,
- K. Patel,
- S. Kornblau,
- E. Jabbour,
- G. Garcia-Manero,
- M. Andreeff,
- N. Daver
Affiliations
- M. Yilmaz
- 1 Leukemia
- M. Muftuoglu
- 1 Leukemia
- H. Kantarjian
- 1 Leukemia
- C. DiNardo
- 1 Leukemia
- T. Kadia
- 1 Leukemia
- G. Borthakur
- 1 Leukemia
- N. Pemmaraju
- 1 Leukemia
- N. Short
- 1 Leukemia
- Y. Alvarado
- 1 Leukemia
- A. Maiti
- 1 Leukemia
- L. Masarova
- 1 Leukemia
- G. Montalban Bravo
- 1 Leukemia
- S. Loghavi
- 2 Hematopathology, MD Anderson Cancer Center, Houston, United States of America
- K. Patel
- 2 Hematopathology, MD Anderson Cancer Center, Houston, United States of America
- S. Kornblau
- 1 Leukemia
- E. Jabbour
- 1 Leukemia
- G. Garcia-Manero
- 1 Leukemia
- M. Andreeff
- 1 Leukemia
- N. Daver
- 1 Leukemia
- DOI
- https://doi.org/10.1097/01.HS9.0000843400.36721.1d
- Journal volume & issue
-
Vol. 6
pp. 28 – 29
Abstract
No abstracts available.